This Article Figures Only Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Zinner, D. E. Search for Related Content PubMed PubMed Citation Articles by Zinner, D. E. Related Collections Pharmaceuticals Research And Technology

Health Tracking

TRENDS

Medical R&D At The Turn Of The Millennium

Historically, medical innovation resulted from the coordinated effort of government, academe, and industry. The past decade has seen the blurring of some of these historical roles and the growing significance of an important fourth player: equity markets. This paper builds on previous work to discuss the current roles of the different sectors in funding medical research and development (R&D), and how current trends may affect its future.¹ Whenever possible, I use examples from the relatively nascent field of biotechnology to illustrate specific points.

Data cited in this paper are gleaned from a wide variety of sources, including government documents, industry . . . [Full Text of this Article]

Government Funding For R&D

 

Academic R&D

 

Industry R&D

 

Venture Capital/Equity Markets

 

Discussion

 

                      What's this?